Stock Price Quote

METROPOLIS HEALTHCARE LTD.

NSE : METROPOLISBSE : 542650ISIN CODE : INE112L01020Industry : Hospital & Healthcare ServicesHouse : Metropolis
BSE1842.95-7.7 (-0.42 %)
PREV CLOSE ( ) 1850.65
OPEN PRICE ( ) 1852.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1714
TODAY'S LOW / HIGH ( )1824.10 1865.25
52 WK LOW / HIGH ( )1555.55 2306.85
NSE1839.30-12.65 (-0.68 %)
PREV CLOSE( ) 1851.95
OPEN PRICE ( ) 1850.00
BID PRICE (QTY) 1839.30 (7)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 191885
TODAY'S LOW / HIGH( ) 1816.65 1862.60
52 WK LOW / HIGH ( )1551.05 2318.3
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-11 2000
Management Info
Sushil Shah - Chairman Ameera Shah - Managing Director
Registered Office

Address 4th Floor, East Wing, Plot-254 B,Nirlon House, Dr. Annie Besant Road,Worli,
Mumbai,
Maharashtra-400030

Phone 022 6258 2810 / 8422 801 801

Email support@metropolisindia.com / secretarial@metropolisindia.com

Website www.metropolisindia.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

04Feb Metropolis Healthcare informs about a
Pursuant to Regulation 30(6) of the Listing Regulations, Metropolis Heal..
10Jan Metropolis Healthcare informs about po
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
31Dec Metropolis Healthcare informs about tr
Metropolis Healthcare has informed that pursuant to the Company’s Code o..
26Dec Metropolis Healthcare incorporates who
Metropolis Healthcare has incorporated as a wholly owned subsidiary (WOS..
10Dec Metropolis Healthcare shines on gettin
Metropolis Healthcare is currently trading at Rs. 2208.85, up by 21.85 p..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit274.051158.9
Gross Profit 368.01 1574.09
Operating Profit 681.342704.78
Net Sales 2968.8111034.25

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Narayana Hrudayalay (BSE)
peergroup  1404.90 (2.35%)
M.Cap ( in Cr)28710.65
Max Healthcare Inst (BSE)
peergroup  1143.60 (1.63%)
M.Cap ( in Cr)111174.17
Vijaya Diagnostic (BSE)
peergroup  1133.25 (0.85%)
M.Cap ( in Cr)11631.26
Dr. Lal Pathlabs (BSE)
peergroup  2810.20 (0.31%)
M.Cap ( in Cr)23489.83
RainbowChildrenS Med (BSE)
peergroup  1382.95 (0.37%)
M.Cap ( in Cr)14044.09

Shareholding Pattern

PROMOTERS 49.4%
NON-INSTITUTION 3.87%
FI/BANKS/INSURANCE 3.5%
MUTUAL FUNDS/UTI 26.37%
GOVERNMENT 0%
FII 0%

About Metropolis Healthcare Ltd.

Metropolis Healthcare Ltd. was incorporated in the year 2000. Its today's share price is 1842.95. Its current market capitalisation stands at Rs 9450.85 Cr. In the latest quarter, company has reported Gross Sales of Rs. 11034.25 Cr and Total Income of Rs.11154.22 Cr. The company's management includes Kamlesh Kulkarni, Aparna Rajadhyaksha, Hemant Sachdev, Anita Ramachandran, Subramanian Ranganathan, Sanjay Bhatnagar, Vivek Gambhir, Ameera Shah, Sushil Shah.

It is listed on the BSE with a BSE Code of 542650 , NSE with an NSE Symbol of METROPOLIS and ISIN of INE112L01020. It's Registered office is at 4th Floor, East Wing, Plot-254 B,Nirlon House, Dr. Annie Besant Road,WorliMumbai-400030, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, Walker Chandiok & Co LLP, Walker, Chandiok & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.